In-Med Prognostics brings affordable, accessible, reliable, and data-driven brain health prognostics and diagnostics tools to India and other emerging markets. Their proprietary software, Neuroshield™ integrates MRI images, clinical reports and psychological assessments to produce automated, quantified reports to support the physician’s clinical impression for various neurological disorders and provides a seamless, end-to-end cloud based image analysis platform for clinical and research use. Leveraging state-of-the-art data analytics and deep learning methodologies, they are developing a biomarker algorithm for various neurological disorders starting with paediatric epilepsy and dementia.
Currently, they offer segmentation services and comparative volumetric analysis reports to clinical end-users and research support for clinical imaging based projects for pharma and life sciences customers. Their aim is to build an Indian databank for neurological disorders consisting of complete clinical data including radiology. In-Med was founded by Rajesh Purushottam, Dr. Latha Poonamallee & Dr. Al Curran.
Website: https://in-medprognostics.com/